Physician profile
Richard Hampton Moore
NPI 1326117433
$1,256.47
in general payments reported to CMS, 2019-2025
16 companies · $229 in 2025
The $229 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $12.27 · 2021: $288 · 2022: $226 · 2023: $186 · 2024: $186 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $276.41 | 2021-2022 | |
| Nevro Corp. | $255.82 | 2021-2023 | Senza |
| Medline Industries LP | $163.81 | 2024 | |
| Averitas Pharma INC. | $129.19 | 2023 | Qutenza |
| Peerless Surgical INC. | $96.23 | 2019-2023 | |
| Treace Medical Concepts, INC. | $65.75 | 2025 | |
| Mimedx Group, INC. | $37.54 | 2025 | |
| Acumed LLC | $35.11 | 2025 | Osteomed, Acumed |
| Zyla Life Sciences, INC. | $31.50 | 2019 | |
| Integra Lifesciences Corporation | $29.31 | 2019 | |
| Abbvie INC. | $26.36 | 2025 | |
| Wright Medical Technology, INC. | $23.60 | 2019-2020 | |
| Kerecis Limited | $23.22 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Abbott Laboratories | $21.69 | 2024 | Eterna |
| Vertex Pharmaceuticals Incorporated | $21.25 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biowound Solutions, INC. | $19.68 | 2025 | Bio-Connekt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.